Use of flash glucose monitoring for blood glucose control in three diabetes patients undergoing maintenance hemodialysis who were hospitalized for COVID‒19 pneumonia-Reference-Cited by-同舟云学术

Use of flash glucose monitoring for blood glucose control in three diabetes patients undergoing maintenance hemodialysis who were hospitalized for COVID‒19 pneumonia

Published:2022 Issue:4 Volume:55 Page:255-264
ISSN:1340-3451
Container-title:Nihon Toseki Igakkai Zasshi
language:en
Short-container-title:Nihon Toseki Igakkai Zasshi

Author:

Mukai Kana¹,Ohshita Kayo¹,Yamashita Kazuomi²,Misuiri Sonoo²,Shigemoto Kenichiro²,Nishizawa Yoshiko²,Doi Toshiki²,Masaki Takao³

Affiliation:

1. Department of Diabetic and Metabolic Medicine, Ichiyokai Harada Hospital

2. Department of Nephrology, Ichiyokai Harada Hospital

3. Department of Nephrology, Hiroshima University Hospital

Publisher

Japanese Society for Dialysis Therapy

Subject

Organic Chemistry,Biochemistry

Link

https://www.jstage.jst.go.jp/article/jsdt/55/4/55_255/_pdf

Reference28 articles.

1. 1） Hsu CM, Weiner DE, Aweh G, et al. COVID‒19 among US dialysis patients： risk factors and outcomes from a national dialysis provider. Am J Kidney Dis 2021； 77： 748‒56.

2. 2）厚生労働省新型コロナウイルス感染症対策推進本部．新型コロナウイルス感染症の軽症者等に係る宿泊療養及び自宅療養の対象並びに自治体における対応に向けた準備について．2020．https://www.mhlw.go.jp/content/000618525.pdf

3. 3） Holman N, Knighton P, Kar P, et al. Risk factors for COVID‒19‒related mortality in people with type 1 and type 2 diabetes in England： a population‒based cohort study. Lancet Diabetes Endocrinol 2020； 8： 823‒33.

4. 4） Zhang Y, Li H, Zhang J, et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019： A single‒centre, retrospective, observational study in Wuhan. Diabetes Obes Metab 2020； 22： 1443‒54.

5. 5） Bode B, Garrett V, Messler J, et al. Glycemic characteristics and clinical outcomes of COVID‒19 patients hospitalized in the United States. J Diabetes Sci Technol 2020； 14： 813‒21.